Document text
Principal Investigator: Mikel Garcia-Marcos
Organization: BOSTON UNIVERSITY MEDICAL CAMPUS
Fiscal Year: 2024
Award: $387,375
Funding agency: National Institute of General Medical Sciences
SIGNIFICANCE: G protein-coupled receptors (GPCRs) are a large family of membrane proteins that initiate
cellular responses to a wide range of extracellular signals, like neurotransmitters or hormones, by activating
heterotrimeric G proteins inside cells. This makes GPCRs critical for many physiological processes and their
dysregulation is frequently associated with disease. GPCRs are not only the family of proteins most widely
targeted by clinically approved drugs, with an estimated market value of hundreds of billions of dollars per
year, but also the subject of many ongoing campaigns towards novel therapeutics. Moreover, many GPCRs
still remain understudied and “undrugged”, which has great untapped potential for future drug discovery.
Despite the biomedical importance of these receptors in physiology and pharmacology, the methodologies
currently used to measure GPCR signaling activity in cells have limitations that hinder progress. One
significant limitation is the use of approaches that compromise the fidelity of the readout because they are too
indirect and/or distort the natural stoichiometry of signaling components. Another significant limitation is that
many of the approaches are only feasible in cells in which gene delivery is easy, limiting their implementation
to a few cell lines instead of more physiologically relevant systems like primary cell cultures.
GOAL: Here, we propose to develop technologies that will allow to measure GPCR signaling activity directly
and in diverse, physiologically-relevant cell systems without introducing major perturbations on the natural
stoichiometry of signaling components. The tools and resources generated in this project will be made
available to other investigators without restrictions.
SYNOPSIS OF AIMS: We will develop two complementary assay platforms based on optical biosensors that
directly detect the activity of heterotrimeric G proteins. In Aim1, we will establish a suite of broadly applicable
“compact” vectors compatible with simple transfection or with viral packaging for the expression of G protein
activity biosensors. In Aim 2, we will validate mouse transgenic lines for the conditional expression of
biosensors of endogenous G protein activity. Collectively, these two platforms will allow the direct assessment
of GPCR signaling activity under native expression conditions, in physiologically relevant cellular systems, and
in formats that enable increased throughput to permit the parallel interrogation of the druggable GPCR-ome.
IMPACT: The achievement of our goal could transform how the large field of research interested in GPCR-
mediated cell communication approaches something as fundamental as measuring signaling activity. The
technologies to be developed here would advance the field by:
(i) enabling the direct characterization of GPCR signaling in systems in which it is currently not possible,
(ii) revealing mechanisms of GPCR signaling with unprecedented fidelity in diverse contexts, and/or
(iii) facilitating pharmacological or mechanistic interrogation in formats compatible with increased throughput.
Terms: <Acceleration><Achievement><Achievement Attainment><Allergy><Area><Assay><Asthma><Astrocytes><Astrocytus><Astroglia><Bioassay><Biological><Biological Assay><Bioluminescence><Biosensor><Breeding><Bronchial Asthma><Cancers><Cardiovascular Diseases><Cell Body><Cell Communication><Cell Communication and Signaling><Cell Interaction><Cell Line><Cell Signaling><Cell Surface Receptors><Cell model><Cell-to-Cell Interaction><CellLine><Cells><Cellular model><Clinical><Culturing, in vitro Vertebrate, Primary><Cytoplasm><Detection><Disease><Disorder><Dissociation><Drug usage><Drugs><Endocrine Gland Secretion><Energy Transfer><Event><Experimental Models><Family><Future><G Protein-Complex Receptor><G Protein-Coupled Receptor Genes><G Protein-Coupled Receptor Signaling><G-Protein-Coupled Receptors><G-Proteins><GPCR><GPCR Signaling><GTP><GTP Binding><GTP bound><GTP-Binding Proteins><GTP-Regulatory Proteins><Gene Delivery><Goals><Guanine Nucleotide Coupling Protein><Guanine Nucleotide Regulatory Proteins><Guanosine Triphosphate><Heterotrimeric G Protein Subunit><Heterotrimeric G-Proteins><Heterotrimeric GTP-Binding Proteins><Hormones><Human Genome><Hypersensitivity><In Vitro><Intracellular Communication and Signaling><Investigators><Malignant Neoplasms><Malignant Tumor><Marketing><Measurement><Measures><Mediating><Medication><Membrane><Membrane Protein Gene><Membrane Proteins><Membrane-Associated Proteins><Methodology><Mice><Mice Mammals><Molecular><Murine><Mus><Names><Nerve Cells><Nerve Transmitter Substances><Nerve Unit><Neural Cell><Neurocyte><Neurons><Neurotransmitters><Opioid Analgesics><Optics><Organism-Level Process><Organismal Process><Pain Control><Pain Therapy><Pain management><Pathway interactions><Pharmaceutical Preparations><Pharmacology><Physiologic><Physiologic Processes><Physiological><Physiological Processes><Physiology><Primary Cell Cultures><Process><Protein Family><Proteins><Receptor Protein><Reporting><Reproducibility><Research><Research Personnel><Research Resources><Researchers><Resources><Signal Transduction><Signal Transduction Systems><Signaling><Strains Cell Lines><Surface Proteins><System><Technology><Therapeutic Hormone><Transfection><Transgenic Mice><Translations><Viral Packaging><Virus Packagings><astrocytic glia><biologic><biological sensor><biological signal transduction><cardiovascular disorder><cell type><cultured cell line><design><designing><dimer><drug discovery><drug use><drug/agent><druggable target><expectation><extracellular><human whole genome><improved><in vivo><interest><malignancy><membrane structure><name><named><naming><neoplasm/cancer><neuronal><neuropsychiatric disease><neuropsychiatric disorder><new drug treatments><new drugs><new pharmacological therapeutic><new therapeutics><new therapy><next generation therapeutics><novel><novel drug treatments><novel drugs><novel pharmaco-therapeutic><novel pharmacological therapeutic><novel therapeutics><novel therapy><opiate analgesia><opiate analgesic><opiate pain medication><opiate pain reliever><opioid analgesia><opioid anesthetic><opioid pain medication><opioid pain reliever><opioid painkiller><optical><optical sensor><pain treatment><pathway><pharmacologic><prototype><receptor><response><sensor><stoichiometry><success><tech development><technology development><tool><translation><vector><virtual>